Docality.com Logo
 
Dr. Virginia Lee Clyburn-Ipock  Md image

Dr. Virginia Lee Clyburn-Ipock Md

555 East Cheves St Mcleod Health Hospital - Radiation Oncology
Florence SC 29506
843 772-2000
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #: TL31724
NPI: 1326276551
Taxonomy Codes:
2085R0001X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

None Found

Publications

Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. - Transplantation
Previously, we had reported the role of tacrolimus (TAC) versus sirolimus (SRL) on the generation of regulatory T cells (Tregs) in primary MLR assays with SRL, demonstrating a uniquely supportive effect. However, the mechanisms associated with their actions on alloreactive human are not fully understood. Therefore, we tested whether TAC and SRL differentially affect already alloactivated human CD4 T-cell subsets.Alloreactive CD4CD45RA/CD45RO T cells generated in 9-day MLR were cocultured with anti-CD3 and autologous antigen presenting cells plus interleukin (IL)-2 in presence of TAC, SRL, or both, and the Tregs generated after another 5 to 6 days were phenotypically, molecularly, and functionally characterized.Tacrolimus significantly and SRL modestly inhibited interferon (IFN)-γ (Th1) and IL-17 (Th17)-producing cells. At clinical therapeutic concentrations, SRL, however, significantly increased forkhead/winged helix transcription factor P3 (FOXP3) Tregs, whereas TAC inhibited this T-cell population dose dependently and significantly. When used in combination, TAC and SRL had additive effects on inhibition of IFN-γ- and IL-17-producing cells. This was in contrast to the ability of SRL to reverse TAC-mediated inhibition of FOXP3-expressing cells. Proinflammatory cytokines (IL-1β, IL-6, and tumor necrosis factor-α) added to cultures caused significant decrease in FOXP3 Tregs that was again reversed by SRL. Sirolimus-derived Tregs were phenotypically normal, anergic to allostimulation, and suppressed proliferation of allogeneic effector T-cells.Thus, although TAC inhibits all alloreactive T cells, SRL promotes the differentiation and expansion of donor-specific Tregs without secondary reprogramming to IFN-γFOXP3 and IL-17FOXP3 Treg subsets. These results, although performed in an artificial in vitro model, add clinically applicable information on how these agents affect T-cell subpopulations.

Map & Directions

555 East Cheves St Mcleod Health Hospital - Radiation Oncology Florence, SC 29506
View Directions In Google Maps

Nearby Doctors

555 E. Cheves St Mcleod Family Medicine Residency Center
Florence, SC 29506
843 772-2812
401 E Cheves St Suite 202
Florence, SC 29506
843 777-7863
555 E Cheves St
Florence, SC 29506
843 772-2800
555 E Cheves St
Florence, SC 29506
843 772-2800
602 E Cheves St
Florence, SC 29506
843 694-4156
555 E Cheves St
Florence, SC 29506
843 772-2314
555 E Cheves St
Florence, SC 29506
843 772-2812
555 E Cheves St
Florence, SC 29506
843 772-2800
305 E Cheves St Suite 330
Florence, SC 29506
843 775-5770